Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian M Kurbacher

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Methods in Molecular Medicine|May 20, 2005
Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurementsChristian M Kurbacher, Ian A Cree
Anti-Cancer Drugs|March 20, 2002
Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatmentMartina Breidenbach, Daniel T Rein, Peter Mallmann, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2005
Treosulfan and gemcitabineIan A Cree, Michael H Neale, Uwe Reinhold, et al.
Anti-Cancer Drugs|August 21, 2007
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancerIan A Cree, Christian M Kurbacher, Alan Lamont, et al.
In Vivo (Athens, Greece)|June 28, 2017
A Head to Head Comparison Between SurgiMend® - Fetal Bovine Acellular Dermal Matrix and Tutomesh® - A Bovine Pericardium Collagen Membrane in Breast Reconstruction in 45 CasesChristian Eichler, Jeria Efremova, Klaus Brunnert, et al.
Anti-Cancer Drugs|September 16, 2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assayLouise A Knight, Mark Conroy, Augusta Fernando, et al.
Anti-Cancer Drugs|June 5, 2003
Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancerMartina Breidenbach, Daniel T Rein, Thomas Schöndorf, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Isolation and culture of ovarian cancer cells and cell linesChristian M Kurbacher, Cornelia Korn, Susanne Dexel, et al.
Anti-Cancer Drugs|March 12, 2004
Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cellsThomas Schöndorf, Markus Hoopmann, Martina Breidenbach, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Methods in Molecular Medicine|May 20, 2005
Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurementsChristian M Kurbacher, Ian A Cree
Anti-Cancer Drugs|March 20, 2002
Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatmentMartina Breidenbach, Daniel T Rein, Peter Mallmann, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2005
Treosulfan and gemcitabineIan A Cree, Michael H Neale, Uwe Reinhold, et al.
Anti-Cancer Drugs|August 21, 2007
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancerIan A Cree, Christian M Kurbacher, Alan Lamont, et al.
In Vivo (Athens, Greece)|June 28, 2017
A Head to Head Comparison Between SurgiMend® - Fetal Bovine Acellular Dermal Matrix and Tutomesh® - A Bovine Pericardium Collagen Membrane in Breast Reconstruction in 45 CasesChristian Eichler, Jeria Efremova, Klaus Brunnert, et al.
Anti-Cancer Drugs|September 16, 2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assayLouise A Knight, Mark Conroy, Augusta Fernando, et al.
Anti-Cancer Drugs|June 5, 2003
Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancerMartina Breidenbach, Daniel T Rein, Thomas Schöndorf, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Isolation and culture of ovarian cancer cells and cell linesChristian M Kurbacher, Cornelia Korn, Susanne Dexel, et al.
Anti-Cancer Drugs|March 12, 2004
Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cellsThomas Schöndorf, Markus Hoopmann, Martina Breidenbach, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Pageof 4